You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

baricitinib

Showing 1 - 25 of 144
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial in Dhaka (Baricitinib 2 MG, Methotrexate 25mg)

Recruiting
  • Rheumatoid Arthritis
  • Baricitinib 2 MG
  • Methotrexate 25mg
  • Dhaka, Bangladesh
    Dr. Md. Abu Shahin
Apr 12, 2023

Traumatic Brain Injury Trial in Xi'an (Baricitinib 4 MG, Standard treatment)

Not yet recruiting
  • Traumatic Brain Injury
  • Baricitinib 4 MG
  • Standard treatment
  • Xi'an, Shaanxi, China
    Tandu Hospital, Fourth Military Medical University
Sep 26, 2023

Vitiligo, Generalized Trial (Baricitinib)

Not yet recruiting
  • Vitiligo, Generalized
  • Baricitinib
  • (no location specified)
Jul 7, 2023

Axial Spondyloarthritis Trial in Dhaka (Baricitinib 2mg, Tofacitinib 5 mg)

Recruiting
  • Axial Spondyloarthritis
  • Baricitinib 2mg
  • Tofacitinib 5 mg
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Nov 1, 2023

NMO Spectrum Disorder Trial in Tianjin (Baricitinib)

Not yet recruiting
  • NMO Spectrum Disorder
  • Baricitinib
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Mar 18, 2023

Mastitis Chronic, Idiopathic Granulomatous Mastitis Trial in Hangzhou (Baricitinib)

Recruiting
  • Mastitis Chronic
  • Idiopathic Granulomatous Mastitis
  • Baricitinib
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
May 9, 2023

Rheumatoid Arthritis Trial in Dhaka (Baricitinib 4 MG, Baricitinib 2 MG)

Recruiting
  • Rheumatoid Arthritis
  • Baricitinib 4 MG
  • Baricitinib 2 MG
  • Dhaka, [Other], Bangladesh
    Dr. Md. Sadikul islam
Dec 13, 2022

Rheumatoid Arthritis Trial in Paris (Baricitinib Oral Tablet [Olumiant], Placebo)

Recruiting
  • Rheumatoid Arthritis
  • Baricitinib Oral Tablet [Olumiant]
  • Placebo
  • Paris, France
    CHU Pitié Salpêtrière
Aug 22, 2022

IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

Recruiting
  • IgG4-related Disease With Eosinophilia
  • Beijing, Bejing, China
    Peking Union Medical College Hospital
Mar 23, 2023

Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)

Not yet recruiting
  • Atopic Dermatitis
  • Baricitinib 4 MG
  • Azathioprine 1.5-2.5 mg/kg
  • Sari, Mazandaran, Iran, Islamic Republic of
    Iran
Aug 1, 2023

Active Non-anterior Non-infectious Uveitis Trial (Baricitinib 4 MG)

Not yet recruiting
  • Active Non-anterior Non-infectious Uveitis
  • Baricitinib 4 MG
  • (no location specified)
Dec 7, 2022

ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Baricitinib
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Sep 27, 2022

Lupus or SLE, Nephritis Trial in Assiut (Baricitinib 4 MG, Baricitinib 2 MG, MMF)

Recruiting
  • Lupus or SLE
  • Nephritis
  • Baricitinib 4 MG
  • +2 more
  • Assiut, Yes, Egypt
    Manal Hassanien
Jan 13, 2023

Areata Alopecia, Alopecia, Hypotrichosis Trial (Baricitinib, Placebo)

Not yet recruiting
  • Areata Alopecia
  • +5 more
  • Baricitinib
  • Placebo
  • (no location specified)
Feb 3, 2023

Human Immunodeficiency Virus Trial in Atlanta (Baricitinib 2 MG Oral Tablet, Placebo)

Not yet recruiting
  • Human Immunodeficiency Virus
  • Baricitinib 2 MG Oral Tablet
  • Placebo
  • Atlanta, Georgia
  • +1 more
Aug 11, 2022

Sjogren's Syndrome Trial in Beijing (Baricitinib, Hydroxychloroquine)

Recruiting
  • Sjogren's Syndrome
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 17, 2022

Post-Acute COVID-19 Syndrome Trial in United States (Baricitinib 4 MG)

Not yet recruiting
  • Post-Acute COVID-19 Syndrome
  • Baricitinib 4 MG
  • San Francisco, California
  • +5 more
May 11, 2023

Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

Active, not recruiting
  • Chronic Graft vs Host Disease
  • Chronic Graft-Versus-Host Disease
  • Baricitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 29, 2022

Dermatomyositis Trial in Paris (Baricitinib, Placebo)

Not yet recruiting
  • Dermatomyositis
  • Baricitinib
  • Placebo
  • Paris, France
    Pitie-Salpêtrière hospital APHP
Jun 7, 2022

Idiopathic Inflammatory Myopathies Trial in London (Baricitinib)

Recruiting
  • Idiopathic Inflammatory Myopathies
  • Baricitinib
  • London, United Kingdom
    King's College Hospital NHS Foundation Trust
May 19, 2022

Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG [Olumiant], Danazol)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
  • +9 more
May 2, 2023

Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, China
  • +9 more
Jul 11, 2023

Dermatomyositis Trial in Seattle (Baricitinib)

Not yet recruiting
  • Dermatomyositis
  • Baricitinib
  • Seattle, Washington
    University of Washington Medical Center
Apr 29, 2022

COVID-19 Trial in Patras (Tocilizumab, Baricitinib)

Recruiting
  • COVID-19
  • Patras, Greece
    University Hospital of Patras, Department of Respiratory Medicin
Apr 5, 2022

Arteritis, Giant Cell Trial in Rochester (Baricitinib)

Completed
Has Results
  • Arteritis, Giant Cell
  • Baricitinib
  • Rochester, Minnesota
    Mayo Clinic
Apr 7, 2022